Figure 1: Participant preferences for receipt of secondary genetic findings.
From: Genomic sequencing identifies secondary findings in a cohort of parent study participants

Participant preferences were assessed for return of genetic variation across a number of different disease categories. An overwhelmingly large majority (85%) of study participants chose to receive any identified secondary variant, regardless of disease association (n = 789). MI, myocardial infarction.